|
Pyrosequencing Inc
pyrosequencing based analysis Pyrosequencing Based Analysis, supplied by Pyrosequencing Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pyrosequencing+based+assay/16s+pyrosequencing+rrna/pm42128334-658-12-12 Average 86 stars, based on 1 article reviews
pyrosequencing based analysis - by Bioz Stars,
2026-09
86/100 stars
|
Buy from Supplier |
|
Pyrosequencing Inc
pyrosequencing based speid technology Pyrosequencing Based Speid Technology, supplied by Pyrosequencing Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pyrosequencing+based+assay/based+pyrosequencing+speid+technology/pmc12642167-178-13-13 Average 86 stars, based on 1 article reviews
pyrosequencing based speid technology - by Bioz Stars,
2026-09
86/100 stars
|
Buy from Supplier |
|
Pyrosequencing Inc
chip based pyrosequencing Chip Based Pyrosequencing, supplied by Pyrosequencing Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pyrosequencing+based+assay/based+chip+pyrosequencing/pm41187758-709-4-5 Average 86 stars, based on 1 article reviews
chip based pyrosequencing - by Bioz Stars,
2026-09
86/100 stars
|
Buy from Supplier |
|
Pyrosequencing Inc
pyrosequencing-based methylation analysis Pyrosequencing Based Methylation Analysis, supplied by Pyrosequencing Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pyrosequencing+based+assay/pyrosequencing+based+methylation+analysis/pm40647502-43-0-0 Average 90 stars, based on 1 article reviews
pyrosequencing-based methylation analysis - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
Pyrosequencing Inc
bisulfite-based pyrosequencing Bisulfite Based Pyrosequencing, supplied by Pyrosequencing Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pyrosequencing+based+assay/bisulfite+pyrosequencing/pmc12054201-156-6-7 Average 90 stars, based on 1 article reviews
bisulfite-based pyrosequencing - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
Pyrosequencing Inc
pyrosequencing-based mgmtp methylation score ![]() Pyrosequencing Based Mgmtp Methylation Score, supplied by Pyrosequencing Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pyrosequencing+based+assay/mgmtp+methylation+specific+pyrosequencing/pmc11877643-149-12-12 Average 90 stars, based on 1 article reviews
pyrosequencing-based mgmtp methylation score - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
|
Pyrosequencing Inc
16s rrna gene-based pyrosequencing surveys ![]() 16s Rrna Gene Based Pyrosequencing Surveys, supplied by Pyrosequencing Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/pyrosequencing+based+assay/16s+rrna+pyrosequencing/pm39581029-104-10-13 Average 90 stars, based on 1 article reviews
16s rrna gene-based pyrosequencing surveys - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
Journal: Neuro-Oncology Advances
Article Title: Clinical value of the MGMT promoter methylation score in IDHmt low-grade glioma for predicting benefit from temozolomide treatment
doi: 10.1093/noajnl/vdae224
Figure Lengend Snippet: Association between progression-free survival (PFS) and the MGMTp methylation score. The association of the MGMTp methylation score, based on the MGMT-STP27 procedure, with progression-free survival (PFS; interval from diagnosis) was evaluated by the hazard ratio (confidence interval at 95%) from the cox regression model. The forest plots in A and B correspond to the PFS reported for patients treated in EORTC-22033 with temozolomide (TMZ) or radiotherapy (RT), respectively. , The MGMT-STP27 score was significant in the TMZ treated patients, but not in the patients with RT. The forest plots in C and D visualize the outcome of the Montpellier patients treated with TMZ, with time to progression defined by the next treatment-free survival (NxtTrtFS), and PFS defined by RANO, respectively. The MGMT-STP27 score was significant in the Montpellier cohort when using NxtTrtFS as outcome measure, a trend was observed when using RANO criteria for PFS. * P <.05; ** P <.01.
Article Snippet: The association between the MGMT-STP27 score and NxtTrtFS was confirmed using a
Techniques: Methylation, Biomarker Discovery